Skip to content



  1. Safety Concerns Halt GVAX Trial August 28, 2008

    An independent safety panel halted a late-stage trial of GVAX, a leading cancer vaccine candidate made by Cell Genesys (CEGE:NASDAQ).

    Read more…


  2. Painfully Exciting Prospects August 15, 2008

    We won't see the results from Zingo's launch until the third quarter. While we are excited to see those numbers, we are more focused on the first and second quarters of 2009. That's when full-scale production will be well under way.

    Read more…


  3. The Long and Winding Road to $20 per Share August 11, 2008

    Analysts expected an even sharper quarter. Maxwell missed Wall Street's number by 6 cents, which, apparently, means big trouble to the share price. Judging by the stock's recent behavior, no one knows what to make of this announcement…

    Read more…


  4. Stock Fortunes: Buy This Garbage Company and Cash in 290% Profits August 1, 2008

    The sound of a diesel engine, the loud reverse beeps and the crash of a Dumpster being unloaded onto the back of a massive garbage truck. That could be the sound of you cashing in…

    Read more…